Natural killer cells show their cancer-fighting worthNatural killer (NK) cells from umbilical-cord blood show promise as a potentially effective and less side-effect-prone alternative to T-cell therapies for blood cancer treatment.
NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cellsNK cells engineered with IL-21 show promising antitumor activity against glioblastoma stem cells, providing a potential new treatment approach.
Natural killer cells show their cancer-fighting worthNatural killer (NK) cells from umbilical-cord blood show promise as a potentially effective and less side-effect-prone alternative to T-cell therapies for blood cancer treatment.
NK cells expressing interleukin-21 show promising antitumor activity in glioblastoma cellsNK cells engineered with IL-21 show promising antitumor activity against glioblastoma stem cells, providing a potential new treatment approach.